Bitterness-reduced intrabuccally quick disintegrating tablets and method for reducing bitterness
The invention relates to a method for reducing bitterness of bitter drugs, which does not cause delay of release rate, does not show reduction of bioavailability in comparison with conventional pharmaceutical preparations and, due to the use of additives generally used in the field of pharmaceutical preparation, has high practical value, and to intrabuccally quick disintegrating tablets having reduced bitterness of bitter drugs. Illustratively, it relates to an intrabuccally quick disintegrating tablet which comprises a bitter drug and a water-insoluble substance having an average particle size of 30 μm or less, wherein the water-insoluble substance disperses as particles on the tongue surface prior to the release of the bitter drug.
1. An intrabucally quick disintegrating dosage form selected from the group consisting of:
(a) a dry-coated tablet which comprises:
(i) an outer layer comprising at least one saccharide and a water-insoluble pharmaceutically and/or coloring agent in the form of particles having an average particle size of 30 μm or less and in an amount of from 20 to 250 mg per tablet, and
(ii) an inner layer or a core comprising a drug having a bitter taste and at least one saccharide, wherein said inner layer or said core is disposed at a position within said outer layer;
(b) laminated or coated granules which comprise:
(i) a core comprising a drug having a bitter taste and at least one saccharide, and
(ii) an outer layer laminated or coated thereon and comprising at least one saccharide and a water-insoluble pharmaceutically acceptable pigment and/or coloring agent in the form of particles having an average particle size of 30 μm or less and in an amount of from 20 to 250 mg per dosage form, wherein said granules are or are not contained in a solid preparation; and
(c) a three-layered tablet which comprises:
an upper and lower layer, each comprising at least one saccharide and a water-insoluble pharmaceutically acceptable pigment and/or coloring agent in the form of particles having an average particle size of 30 μm or less and in an amount of from 20 to 250 mg per tablet, arranged on an intermediate layer which comprises a drug having a bitter taste and at least one saccharide, wherein
when the dosage form is taken in the mouth, said water-insoluble pharmaceutically acceptable pigment and/or coloring agent is dispersed as particles and the dispersion of the particles starts 1 to 10 seconds prior to release of the drug having the bitter taste.
2. The intrabucally quick disintegrating dosage form according to claim 1 , wherein the drug content is from 0.5 to 85% by weight based on the whole dosage form.
3. The intrabucally quick disintegrating dosage form according to claim 2 , which is said three-layered tablet.
4. The intrabuccally quick disintegrating dosage form according to claim 1 , wherein the pigment and/or coloring agent is at least one of titanium oxide or talc.
5. The intrabuccally quick disintegrating dosage form according to claim 1 , wherein at least one saccharide is a granulated product prepared by spraying, coating and/or granulating a saccharide having low moldability with a saccharide having high moldability.
6. The intrabuccally quick disintegrating dosage form according to claim 5 , wherein the production process contains humidification and drying steps.
7. The intrabuccally quick disintegrating dosage form according to claim 6 , wherein the saccharide having low moldability is one or more saccharides selected from the group consisting of lactose, mannitol, glucose, sucrose, xylitol and erythritol.
8. The intrabuccally quick disintegrating dosage form according to claim 6 , wherein the saccharide having high moldability is one or more saccharides selected from the group consisting of maltose, maltitol, sorbitol and trehalose.
9. The intrabuccally quick dosage form according to claim 1 , which is said three-layered tablet.
10. The intrabuccally disintegrating dosage form according to claim 1 , wherein the dry-coated tablet comprises an outer layer containing the pigment and/or coloring agent and a core containing the drug.
11. The intrabuccally disintegrating dosage form according to claim 1 , wherein the granules are contained in a solid preparation which is a monolithic tablet.
12. A method for reducing bitterness in the mouth when administering a bitter drug, said method comprising orally administering the intrabuccally quick disintegrating dosage form of claim 1 , and wherein said method is effected by dispersing and retaining as particles the pigment and/or coloring agent on the tongue surface prior to release of the drug having a bitter taste.
13. The method according to claim 12 , wherein at least one saccharide is a granulated product prepared by spraying, coating and/or granulating a saccharide having low moldability with a saccharide having high moldability.
14. The method according to claim 13 , wherein the production process contains humidification and drying steps.
15. The method according to claim 14 , wherein the saccharide having low moldability is one or more saccharides selected from the group consisting of lactose, mannitol, glucose, sucrose, xylitol and erythritol.
16. The method according to claim 14 , wherein the saccharide having high moldability is one or more saccharides selected from the group consisting of maltose, maltitol, sorbitol and trehalose.
17. The method according to claim 12 , wherein the water-insoluble substance is at least one member selected from the group consisting of titanium oxide and talc.